Sort
30,917 grants matching “tumor microenvironment”
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis
$446,785Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Therapeutic Targeting in EGFR-amplified Glioblastoma
$446,750Shi-Yuan Cheng · Northwestern University At Chicago · R01 · FY2025 · NS
Data Processing, Analysis and Modeling Unit
$446,714Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2018 · CA
Mechanisms and therapeutic targeting of osteoimmune functions of RANKL in breast cancer
$446,708Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2023 · CA
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$446,690Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DE
Core--Molecular Genetics
$446,686University Of Arkansas Med Scis Ltl Rock · P01 · FY2004 · CA
Determination of functional and molecular biomarkers of treatment resistance with multimodal optical spectroscopy
$446,648Narasimhan Rajaram · University Of Arkansas At Fayetteville · R01 · FY2019 · CA
Targeting the MET Pathway in Urothelial Carcinoma
$446,627Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Downstream of Akt in the tumor vessel
$446,580Laura E Benjamin · Beth Israel Deaconess Medical Center · R01 · FY2008 · CA
Estrogen and Its Receptors in Angiogenesis
$446,579Charlotte Kuperwasser · Beth Israel Deaconess Medical Center · P01 · FY2009 · CA
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$446,575Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2023 · CA
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$446,575Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2022 · CA
Regulation of Hypoxia-Inducible Factors in Pluripotent Cancer Cells.
$446,534John Niederhuber · Basic Sciences · Z01 · FY2007 · CA
Examining Sexual Dimorphisms: The Role of Estradiol Signaling in Modulating Immunity
$446,528Stephen R Hammes · University Of Rochester · R01 · FY2024 · HL
WEE1 inhibition and tumor immunity
$446,500Bin Zhang · Northwestern University At Chicago · R01 · FY2018 · CA
ADPKD: Understanding immunosuppression mechanisms and discovering treatment
$446,491Xiaogang Li · Mayo Clinic Rochester · R01 · FY2024 · DK
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM
$446,457Sangeeta Goswami · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer
$446,456David D Schlaepfer · University Of California, San Diego · R01 · FY2024 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$446,417Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2020 · CA
Revealing the Biophysics of the Germinal Center Microenvironment
$446,400Robert Koehler Abbott · University Of Texas Med Br Galveston · DP2 · FY2022 · AI
A Bioprinted Volumetric Model of Vascularized Glioblastoma
$446,380Y. Shrike Zhang · Brigham And Women'S Hospital · R01 · FY2023 · CA
Targeting Lipid Metabolism in the Tumor Microenvironment
$446,352Ashani T Weeraratna · Wistar Institute · P01 · FY2020 · CA
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
$446,342Rahul Anil Sheth · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Liver kinase B1 in angiogenesis
$446,284Ming-Hui Zou · Georgia State University · R01 · FY2019 · CA
Targeting innate immune pathways in breast cancers with chromosomal instability
$446,239Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA